fig2
![Interplay among norepinephrine, NOX2, and neuroinflammation: key players in Parkinson's disease and prime targets for therapies](https://image.oaes.cc/9945e58a-9879-4413-99f2-1a3cbfc511f4/4260.fig.2.jpg)
Figure 2. DSP-4 injection causes progressive neuronal loss along the gut-brain axis. DSP-4-induced chronic inflammatory models display progressive ascending neuronal loss along a caudal-rostral axis, which recapitulates the spatiotemporal order of neurodegeneration in PD. Furthermore, the colon is an early site affected after injection with DSP-4[137]. α-synuclein pathology and enteric neuronal loss were initially found in the large intestine at one month, while neurodegeneration in the brain was observed a few months later, indicating progressive neurodegeneration occurs along the gut-brain axis.